"Thus far in 2008, we have completed two acquisitions, including one which will enhance our product portfolio and pipeline of new drugs and another which will allow us to quickly expand sales of our medicinal products. In 2008, we expect strong growth in all of our product categories, with sales of bio- chemical products and our highly successful Slim Patch making the largest contributions," said Mr. Liu. "For the full year 2008, and as a result of our recent acquisitions, we are currently on track to increase revenues materially as compared to last year and hope to increase our gross margin to approximately 78.5%."
The Company will conduct a conference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discuss the first quarter 2008 results. To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (888)552-2116. International callers should dial (706)634-2457. The Conference ID for this call is 47653429. If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Thursday, May 15, 2008 at 7:00 p.m. Eastern Time. To access the replay, dial (800)642-1687, international callers dial (706)645-9291, conference ID 47653429.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is engaged in the
manufacturing, marketing and distribution of pharmaceutical, medicinal and
diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di
Ren Medical Science Technology Company, Harbin First Bio-Engineering
Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc.,") and
Heilongjiang Haina Pharmaceutical Inc., the Company manufactures and
|SOURCE China Sky One Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved